Bottom line
What does IBBQ hold?
IBBQ held 261 positions as of May 31, 2026. Its largest holding is Invesco Private Prime Fund at 14.20% of the fund, and the top 10 positions add up to 56.6%. By asset type it is 100% stocks, 20% cash & short-term funds.
Updated Jul 28, 2026
IBBQ top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | Cash & short-term funds | 14.20% | $9.6M |
| 2 | Gilead Sciences, Inc. | Stocks | 7.39% | $5.0M |
| 3 | Vertex Pharmaceuticals Inc. | Stocks | 7.38% | $5.0M |
| 4 | Amgen Inc. | Stocks | 7.10% | $4.8M |
| 5 | Invesco Private Government Fund | Cash & short-term funds | 5.48% | $3.7M |
| 6 | Regeneron Pharmaceuticals, Inc. | Stocks | 5.08% | $3.4M |
| 7 | Alnylam Pharmaceuticals, Inc. | Stocks | 3.19% | $2.1M |
| 8 | Revolution Medicines, Inc. | Stocks | 2.48% | $1.7M |
| 9 | Biogen Inc. | Stocks | 2.29% | $1.5M |
| 10 | Illumina, Inc. | Stocks | 1.98% | $1.3M |
| 11 | United Therapeutics Corp. | Stocks | 1.94% | $1.3M |
| 12 | Royalty Pharma PLC Royalty Pharma PLC, Class A |
Stocks | 1.90% | $1.3M |
| 13 | argenx SE argenx SE, ADR |
Stocks | 1.89% | $1.3M |
| 14 | Insmed Inc. | Stocks | 1.83% | $1.2M |
| 15 | Roivant Sciences Ltd. | Stocks | 1.71% | $1.2M |
| 16 | Incyte Corp. | Stocks | 1.53% | $1.0M |
| 17 | Viatris Inc. | Stocks | 1.49% | $1.0M |
| 18 | Moderna, Inc. | Stocks | 1.48% | $999.2K |
| 19 | Guardant Health, Inc. | Stocks | 1.35% | $912.0K |
| 20 | Neurocrine Biosciences, Inc. | Stocks | 1.26% | $851.8K |
| 21 | Jazz Pharmaceuticals PLC | Stocks | 1.16% | $780.4K |
| 22 | Ascendis Pharma A/S | Stocks | 1.10% | $739.8K |
| 23 | Summit Therapeutics Inc. | Stocks | 1.08% | $729.1K |
| 24 | Exelixis, Inc. | Stocks | 1.04% | $702.8K |
| 25 | BridgeBio Pharma, Inc. | Stocks | 1.02% | $688.6K |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 28, 2026